Market Tracker

10/20 3:53pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

36.34
BATS BZX Real-Time Price
As of 3:52pm ET
 +0.51 / +1.42%
Today’s Change
20.68
Today|||52-Week Range
41.20
+26.01%
Year-to-Date
Valeant Reports Positive Results on Psoriasis Drug Siliq
Oct 13 / Zacks.com - Paid Partner Content
Why Should You Invest in Novo Nordisk (NVO) Stock Right Now
Oct 10 / Zacks.com - Paid Partner Content
Lilly's Verzenio Gets Priority Review in First-Line Setting
Oct 13 / Zacks.com - Paid Partner Content
AstraZeneca's Tagrisso Gets Breakthrough Therapy Designation
Oct 09 / Zacks.com - Paid Partner Content
Here's Why Intercept (ICPT) Stock Lost 37% So Far in 2017
Oct 12 / Zacks.com - Paid Partner Content
Emergent BioSolutions Acquires Sanofi's Smallpox Vaccine Unit
Oct 09 / Zacks.com - Paid Partner Content
Allergan's Uterine Fibroids Candidate's NDA Accepted by FDA
Oct 11 / Zacks.com - Paid Partner Content
Roche (RHHBY) Receives FDA Approval For Cobas Zika Test
Oct 09 / Zacks.com - Paid Partner Content
Mallinckrodt to Begin Sarcoidosis Study on Acthar Gel
Oct 10 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close35.83
Today’s open35.94
Day’s range35.34 - 36.54
Volume50,836
Average volume (3 months)1,443,762
Market cap$4.4B
Dividend yield--
Data as of 3:52pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)-9.02%
Earnings growth (next 5 years)+33.12%
Revenue growth (last year)+28,311.48%
P/E ratioNM
Price/Sales192.80
Price/Book8.39

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-0.33-0.31%
AGNPRAAllergan plc-4.60-0.67%
AKRXAkorn Inc+0.18+0.53%
VRXValeant Pharmaceutic...-0.36-2.88%
Data as of 3:53pm ET, 10/20/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$17.3M
Annual profit (last year)-$271.4M
Net profit margin-1,565.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Senior VP-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts